Barbara Lindheim | Consulting Vice President Investor & Public Relations |
Dale Pfost | Chairman & CEO |
David Weiner | Interim CMO |
Don Marvin | CFO, COO & EVP |
Adi Mor | Co-Founder & Chief Scientific Officer |
Kristen Kluska | Cantor Fitzgerald |
Jeff Jones | Oppenheimer |
Nathan Weinstein | Aegis Capital |
Greetings and welcome to the Chemomab First Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I'd now like to turn the conference over to your host Barbara Lindheim, Consulting Vice President, Strategic Communications for Chemomab.